Viking Therapeutics (VKTX) News Today → RSVP: Charles Payne’s Cash Flow Workshop (From Unstoppable Prosperity) (Ad) Free VKTX Stock Alerts $55.99 +0.98 (+1.78%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 8:45 AM | fool.comThis High-Flying Stock Just Announced More Good News: Time to Buy?June 9 at 5:01 AM | marketbeat.comCampbell & CO Investment Adviser LLC Makes New $545,000 Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Campbell & CO Investment Adviser LLC acquired a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 29,278 shares of the biotechnology company's stock,June 8 at 7:40 AM | investorplace.comProfiting from the Crowd: 3 Stocks Set to Surge on Retail Investor EnthusiasmJune 8 at 6:34 AM | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Trading Down 4.6%June 7 at 11:15 AM | seekingalpha.comViking Therapeutics: MASH Data Punished By Wall Street Amid GLP-1 UncertaintyJune 7 at 6:18 AM | marketbeat.com14,571 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Acquired by NEOS Investment Management LLCNEOS Investment Management LLC acquired a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 14,571 shares of the biotechnology company's stock, valued at approximatJune 6 at 7:45 AM | fool.comIs Viking Therapeutics Stock a Buy on the Dip?June 6 at 7:25 AM | marketbeat.comRafferty Asset Management LLC Sells 146,902 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Rafferty Asset Management LLC lowered its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 26.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 413,278 shares of the biotechnology compaJune 6 at 2:58 AM | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Rating Reiterated by HC WainwrightJune 6 at 2:14 AM | americanbankingnews.comViking Therapeutics' (VKTX) "Buy" Rating Reaffirmed at Maxim GroupJune 6 at 1:42 AM | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Rating Reiterated by Raymond JamesJune 5, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading 3.7% Higher Viking Therapeutics (NASDAQ:VKTX) Trading 3.7% HigherJune 5, 2024 | marketbeat.comSteward Partners Investment Advisory LLC Buys 21,246 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Steward Partners Investment Advisory LLC lifted its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 121.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,746 shares of tJune 4, 2024 | markets.businessinsider.comViking Therapeutics Reports Positive 52-week Histologic Data From Phase 2b VOYAGE Study Of VK2809 June 4, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Up to $62.27Viking Therapeutics (NASDAQ:VKTX) Shares Gap Up to $62.27June 4, 2024 | marketbeat.comEagle Asset Management Inc. Makes New $4.87 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Eagle Asset Management Inc. purchased a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 261,783 shares of the biotechnology company's stock, vaJune 4, 2024 | prnewswire.comViking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)June 3, 2024 | fool.com1 Disruptive Biotech Stock to Buy Now, and 1 to ConsiderJune 3, 2024 | fool.comThe Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.June 3, 2024 | marketbeat.comDorsey & Whitney Trust CO LLC Takes Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Dorsey & Whitney Trust CO LLC bought a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 18,343 shares of the biotechnology company's stoJune 1, 2024 | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Upgraded by StockNews.com to SellMay 31, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Rating Increased to Sell at StockNews.comStockNews.com raised shares of Viking Therapeutics to a "sell" rating in a research note on Friday.May 30, 2024 | prnewswire.comViking Therapeutics to Participate at Upcoming Investor ConferencesMay 29, 2024 | investorplace.comIf You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 NamesMay 27, 2024 | msn.comSA Asks: Who will launch the next big weight-loss drug?May 27, 2024 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Rating of "Buy" from AnalystsViking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) has been assigned a consensus rating of "Buy" from the ten ratings firms that are currently covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to tMay 26, 2024 | fool.comIf You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have TodayMay 25, 2024 | msn.comViking, CRISPR, Intellia among potential M&A targets: Wells FargoMay 25, 2024 | investorplace.com3 Biotech Stocks That Could Be Millionaire-Makers: May EditionMay 25, 2024 | fool.comWhere Will Viking Therapeutics Be in 5 Years?May 24, 2024 | fool.com2 Stocks That Could 10x by 2035May 23, 2024 | investorplace.comDip Then Rip? 3 Nasdaq Stocks to Buy Before the ReboundMay 22, 2024 | fool.comIs It Too Late to Buy Viking Therapeutics Stock?May 22, 2024 | marketbeat.comSwiss National Bank Sells 29,900 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Swiss National Bank cut its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 15.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 167,600 shares of the biotechnology company's stock after selling 29,900 sharesMay 21, 2024 | investorplace.com3 Growth Stocks That Could Be Millionaire-Makers: May EditionMay 21, 2024 | marketbeat.comLevel Four Advisory Services LLC Increases Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Level Four Advisory Services LLC grew its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 87.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 31,374 shares of the biotechnology company's stock after buying an additional 14,638 shareMay 20, 2024 | investorplace.comWall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for May 2024May 19, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Makes New $12.34 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Massachusetts Financial Services Co. MA acquired a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 663,May 18, 2024 | fool.com3 Monster Stocks in the Making You Can Buy Right NowMay 17, 2024 | investorplace.comPharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?May 17, 2024 | msn.comRaymond James Upgrades Viking Therapeutics (VKTX)May 17, 2024 | baystreet.caStock Sell Alerts: Cisco Systems, Viking Therapeutics, B. RileyMay 17, 2024 | fool.comIs Viking Therapeutics Stock a Buy?May 16, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Down to $78.01Viking Therapeutics (NASDAQ:VKTX) Shares Gap Down to $78.01May 16, 2024 | msn.comViking falls after Roche’s obesity drug data; RayJay upgrades (update)May 16, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Raised to "Strong-Buy" at Raymond JamesRaymond James raised Viking Therapeutics from an "outperform" rating to a "strong-buy" rating and increased their price target for the company from $115.00 to $116.00 in a report on Thursday.May 16, 2024 | marketbeat.comViking Therapeutics' (VKTX) Buy Rating Reaffirmed at Truist FinancialTruist Financial reaffirmed a "buy" rating and issued a $120.00 price objective on shares of Viking Therapeutics in a research note on Thursday.May 16, 2024 | investorplace.comTiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000May 15, 2024 | benzinga.comHere's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth TodayMay 14, 2024 | investorplace.comDouble-Up Delights: 7 Stocks Poised to Soar 100% by 2025 Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Hurry! Buy this stock before the Robinhood traders do! (Ad)Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here. Click here to pay just $5 for a full year of Stealth Trades VKTX Media Mentions By Week VKTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.660.76▲Average Medical News Sentiment VKTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼237▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Prothena News Today Puma Biotechnology News Today Marinus Pharmaceuticals News Today Teva Pharmaceutical Industries News Today Alnylam Pharmaceuticals News Today Genmab A/S News Today Royalty Pharma News Today BioMarin Pharmaceutical News Today BeiGene News Today Viatris News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored